在肺癌手术中,CYP2D6基因多态影响术后疼痛敏感性和药物反应
Xiaoyu Zhang1, Xitong Zhang1, Lei Yang2
1Department of Anesthesiology, Jilin Province Cancer Hospital Changchun 130021, Jilin, China.
International journal of clinical and experimental pathology
|February 9, 2026
概括
CYP2D6基因表达影响肺癌患者的术后疼痛. 低CYP2D6活性导致更好的疼痛缓解,支持个性化疼痛管理策略.
科学领域:
- 药物基因组学 药物基因组学
- 在瘤学瘤学.
- 疼痛管理 疼痛管理
背景情况:
- 胸腔镜肺部手术在治疗术后疼痛方面存在挑战.
- 药物反应的个体变化需要个性化治疗方法.
- 细胞染色体P450 2D6 (CYP2D6) 酶在药物代谢中起着至关重要的作用.
研究的目的:
- 研究CYP2D6基因多态表达与术后疼痛敏感性之间的关联.
- 评估CYP2D6活性对肺癌患者对止痛药的个性化药物反应的影响.
- 探索CYP2D6基因定型在胸腔镜手术后优化疼痛管理的潜力.
主要方法:
- 接受胸腔镜手术的60名肺癌患者被基因定型为CYP2D6的表达.
- 患者被分为高 (I组) 和低 (II组) 的CYP2D6活性组.
- 评估了术后疼痛 (VAS),止痛药消耗 (PCA),不良事件和恢复参数.
主要成果:
- 较高的CYP2D6表达与增加的疼痛评分和止痛需求相关.
- 低CYP2D6活性患者经历了长时间的镇痛和较少的不良事件.
- 低CYP2D6活性与更早的出行和更短的住院时间有关.
结论:
- CYP2D6活性显著影响术后疼痛感知和镇痛效果.
- 在肺癌手术中,CYP2D6基因定型可以指导个性化疼痛管理策略.
- 根据CYP2D6基因型量身定制的止痛药可以改善恢复并降低医疗保健成本.
相关概念视频
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
371
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
371
Factors Influencing Drug Absorption: Drug Dissolution
1.2K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.2K
Hepatic Drug Excretion: Influencing Factors
597
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
597
Factors Influencing Drug Absorption: Pharmaceutical Parameters
569
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
569
Factors Influencing Drug Absorption: Presystemic Elimination
926
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
926
Factors Influencing Drug Absorption: Anatomical Parameters
642
Drug absorption involves the movement of drugs from the point of administration into the systemic circulation. Initially, Gastrointestinal (GI) motility propels the drug through the digestive tract and into the stomach. However, the stomach's high acidity and limited surface area restrict its role in drug absorption for most drugs. The drug then moves from the stomach to the small intestine via gastric emptying, which can be slowed by various factors, including interactions with other...
642


